Assyro AI

FDA Orange Book · active-ingredient family

Sulfisoxazole

Sulfisoxazole is approved as 1 brand and 18 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:GANTRISIN · NDA 006525

1

Brand (NDA)

18

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
GANTRISINROCHENDA 006525Approved Prior to Jan 1, 1982

Generic (ANDA) products (18)

ProductApplicantApplicationTEApproved
SOSOLMK LABSANDA 080036Approved Prior to Jan 1, 1982
SOXAZOLEALRAANDA 080366Approved Prior to Jan 1, 1982
SULFALARPARKE DAVISANDA 084955Approved Prior to Jan 1, 1982
SULFISOXAZOLEANI PHARMSANDA 080142Approved Prior to Jan 1, 1982
SULFISOXAZOLEBARRANDA 084031Approved Prior to Jan 1, 1982
SULFISOXAZOLEHEATHERANDA 080189Approved Prior to Jan 1, 1982
SULFISOXAZOLEIMPAX LABSANDA 080109Approved Prior to Jan 1, 1982
SULFISOXAZOLELANNETTANDA 080085Approved Prior to Jan 1, 1982
SULFISOXAZOLELEDERLEANDA 087649Approved Prior to Jan 1, 1982
SULFISOXAZOLEPHARMERALANDA 084385Approved Prior to Jan 1, 1982
SULFISOXAZOLEPUREPAC PHARMANDA 080087Approved Prior to Jan 1, 1982
SULFISOXAZOLERISINGANDA 085628Approved Prior to Jan 1, 1982
SULFISOXAZOLEROXANEANDA 080082Approved Prior to Jan 1, 1982
SULFISOXAZOLEVALEANT PHARM INTLANDA 080268Approved Prior to Jan 1, 1982
SULFISOXAZOLEVITARINEANDA 087332Approved Prior to Jan 1, 1982
SULFISOXAZOLEWATSON LABSANDA 085534Approved Prior to Jan 1, 1982
SULFISOXAZOLEWEST WARDANDA 080379Approved Prior to Jan 1, 1982
SULSOXINSOLVAYANDA 080040Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sulfisoxazole — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.